Chart calendar XSPY PHAR
Upcoming events on XSPY PHAR
Past events on XSPY PHAR
2024-06-03 10:00 | American Society of Clinical Oncology Meeting - Abstract No :6561 |
2024-05-21 04:00 | Annual General Meeting |
2024-05-07 | Q1 2024 Earnings Release |
2024-03-20 06:10 | Redeye Theme: Commercialization in Life Science |
2024-02-13 | Q4 2023 Earnings Release |
2024-01-24 07:19 | Redeye Theme: Fight Cancer |
2023-11-07 | Q3 2023 Earnings Release |
2023-08-01 | Q2 2023 Earnings Release |
2023-06-01 00:00 | Redeye Growth Day |
2023-05-24 | Extraordinary Shareholders Meeting |
2023-05-16 04:00 | Annual General Meeting |
2023-05-03 | Q1 2023 Earnings Release |
2023-03-06 | Redeye Commercialization Conference |
2023-02-14 | FY 2022 Earnings Release |
2023-01-19 00:00 | Redeye Fight Cancer Seminar |
2022-12-12 18:00 | American Society of Hematology Meeting |
2022-11-26 | Redeye Life Science Day_Interview |
2022-11-08 | Q3 2022 Earnings Release |
2022-09-06 | Pareto Securities Healthcare Conference |
2022-08-05 02:30 | Interim 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,42 - | 0,00 0,22 - | 713 |
EBITDA Million SEK | Released Forecast Spread | -41,8 -72,0 42% | 0,00 | -89,1 -63,8 -39.57% | -124 -239 48.33% | -173 -153 -12.44% | -278 |
EBIT Million SEK | Released Forecast Spread | -46,6 -73,0 36.21% | 0,00 | -98,0 -68,3 -43.36% | -133 -239 44.34% | -182 -230 20.99% | -293 |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -45,8 -73,0 37.3% | 0,00 | -96,7 -75,4 -28.2% | -132 -238 44.64% | -180 -88,9 -102.08% | 754 |
Net income Million SEK | Released Forecast Spread | -45,8 -73,0 37.3% | -52,4 | -96,7 -75,4 -28.2% | -132 -238 44.64% | -180 -88,9 -102.06% | 596 |
EPS SEK | Released Forecast Spread | -3,01 0,00 - | -3,05 | -5,03 -3,96 -27.05% | -6,25 -8,55 26.88% | -6,76 -3,20 -111.53% | 21,4 |
Announcement Date | 28/02/20 | 25/02/21 | 18/02/22 | 15/02/23 | 14/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 |
---|---|---|---|---|---|
EBITDA Million SEK | Released Forecast Spread | -17,0 -60,0 71.73% | -26,8 -22,0 -21.92% | -26,6 -60,0 55.68% | -53,2 -60,0 11.4% |
EBIT Million SEK | Released Forecast Spread | -19,3 -60,0 67.86% | -29,2 -22,0 -32.77% | -29,0 -60,0 51.68% | -55,6 -60,0 7.36% |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -18,9 -59,0 67.91% | -28,9 -22,0 -31.45% | -28,7 -59,5 51.81% | -55,2 -59,5 7.12% |
Net income Million SEK | Released Forecast Spread | -18,9 -59,0 67.91% | -28,9 -22,0 -31.45% | -28,7 -59,5 51.81% | -55,2 -59,5 7.12% |
EPS SEK | Released Forecast Spread | -0,92 -2,53 63.64% | -1,40 -0,93 -50.06% | -1,39 -2,53 44.97% | -2,48 -2,14 -16.06% |
Announcement Date | 06/05/22 | 05/08/22 | 09/11/22 | 15/02/23 |
Past sector events for XSPY PHAR
2024-06-05 03:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |